Cost-effectiveness of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease in the UK.pptx (254.64 kB)
Download fileCost-effectiveness of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease in the UK (2012)
poster
posted on 2020-02-28, 11:41 authored by Yang MengYang Meng, Hazel SquiresHazel Squires, John Stevens, Emma SimpsonEmma Simpson, Steve Thomas, Jonathan Michaels, Gerard Stansby, Mark O'DonnellThe study aims to assess the cost-effectiveness of the vasoactive drugs cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for intermittent claudication due to peripheral arterial disease (PAD) in adults whose symptoms continue despite a period of conservative management.
History
Ethics
The project has ethical approval and have included the number in the description fieldPolicy
The data complies with the institution and funders' policies on access and sharingSharing and access restrictions
The data can be shared openlyData description
- The file formats are open or commonly used
Methodology, headings and units
- Headings and units are explained in the files
CC BY 4.0